Article
The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast, Schizosaccharomyces pombe.
Cell motility and the cytoskeleton - 1 Jan 1998
May K M, Wheatley S P, Amin V, Hyams J S
Abstract excerpt
The growth of fission yeast cultures was reversibly inhibited by exposure to the myosin-ATPase inhibitor 2,3-butanedione-2-monoxime (BDM). Wild-type cells treated with 20 mM BDM for approximately two generation times were smaller than untreated controls and had a septation index approximately twice that seen in the absence of the inhibitor. The organization of actin at the cell poles was somewhat disorganized in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.